Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Marisa Egan

Marisa Egan

Saint Joseph’s University, USA

Title: Investigation of the role of the sRNA RyhB in regulating the locus of enterocyte effacement pathogenicity Island in enteropathogenic Escherichia coli

Biography

Biography: Marisa Egan

Abstract

Enteropathogenic Escherichia coli, commonly known as EPEC is a diarrheal pathogen that infects infants in developing countries. The bacterium belongs to the attaching and effacing (A/E) morphotype of pathogenic E. coli, since it infects infants by directly binding to intestinal epithelial cells and destroying the microvilli. The virulence of EPEC is attributed to its major pathogenicity island: The locus of enterocyte effacement (LEE). Treatment of EPEC infections is particularly challenging, because currently there are no vaccines against this bacterium. The problem is only exacerbated by the emergence of multi-drug resistant strains of EPEC. Thus, understanding the regulatory pathways that govern the LEE is critical towards the development of effective measures to combat EPEC infections. The LEE is responsive to a myriad of environmental cues with the majority of them targeting three LEE-encoded transcription factors: Ler, GrlR, and GrlA. Whereas transcriptional regulation of the LEE has been widely characterized, post transcriptional regulation including regulation by trans-encoded regulatory small RNAs (sRNAs), remains understudied. Most sRNAs exert their effects by directly base-pairing to their target mRNAs to influence the translation and/or stability of the target mRNA. A subset of these sRNAs requires Hfq, a chaperone protein that assists in the finding and base-pairing of sRNAs to their target mRNAs. One such sRNA is RyhB. Preliminary results suggest that Hfq and RyhB core press the grlRA mRNA that encodes GrlR and GrlA. To better understand the mechanism of action of RyhB on the grlRA mRNA, we preformed in silico alignment analysis. By using IntaRNA, we identified regions of complementarity between RyhB and the ribosomal binding site, in the 5’ untranslated region (UTR), of the upstream gene grlR in the grlRA mRNA. In order to confirm this prediction of direct base-pairing between RyhB and grlRA, we constructed a polynucleotide mutation in the seed region of RyhB; this mutation completely abolished the ability of the mutant RyhB to base pair to and represses the grlR-lacZ fusion. Thus, collectively, our results suggest that RyhB represses the LEE by directing base-pairing to the leader segment of the grlRA mRNA and preventing the expression of both GrlR and GrlA. Future studies are aimed at further understanding the RyhB-mediated regulation of the LEE by genetic, biochemical and phenotypic assays to with the goal of developing efficacious and potent pharmacological targets against EPEC.